JP Morgan Chase’s Array Biopharma Inc ARRY Stock Holding History

JP Morgan Chase’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-127,000	Closed	-$3.1M	–	6160
2019 Q1	$3.1M	Buy	+127,000	New	+$2.64M	﹤0.01%	3008
2018 Q2	–	Sell	-45,000	Closed	-$734K	–	5805
2018 Q1	$734K	Sell	45,000 -450,000	-91%	-$7.21M	﹤0.01%	3839
2017 Q4	$6.34M	Buy	495,000 +50,000	+11%	+$569K	﹤0.01%	2478
2017 Q3	$5.45M	Hold	445,000	–	–	﹤0.01%	2508
2017 Q2	$3.73M	Buy	445,000 +45,000	+11%	+$368K	﹤0.01%	2676
2017 Q1	$3.58M	Buy	+400,000	New	+$4.26M	﹤0.01%	2653

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

JP Morgan Chase's ARRY Position: Q3 2019 in Review

JP Morgan Chase sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,462,833 shares — an estimated $67.6M sold.

JP Morgan Chase first reported a position in ARRY in Q2 2013 and held it in 20 quarters. The position peaked at $67.6M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

JP Morgan Chase reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
JP Morgan Chase sold 1,462,833 Array Biopharma Inc shares in Q3 2019, an estimated $67.6M.
JP Morgan Chase first reported a position in Array Biopharma Inc in Q2 2013 and held it in 20 quarters.
JP Morgan Chase's Array Biopharma Inc position peaked at $67.6M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.